Diffusion Magnetic Resonance Imaging Detects Pathologically Confirmed, Nonenhancing Tumor Progression in a Patient With Recurrent Glioblastoma Receiving Bevacizumab

被引：78

作者：

Gerstner, Elizabeth R. ^{[1
]}

Frosch, Matthew P.

Batchelor, Tracy T.

机构：

[1] Massachusetts Gen Hosp, Ctr Canc, Dept Neurol, Boston, MA 02114 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 06期

关键词：

PROLONGS SURVIVAL; KINASE INHIBITOR; ANTIBODY; GROWTH; GLIOMA; EDEMA;

D O I：

10.1200/JCO.2009.25.0233

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：E91 / E93

页数：3

共 11 条

[1] Diffusion-weighted imaging of primary brain lymphomas: Effect of ADC value and signal intensity of T2-weighted imaging [J].

Akter, Masuma ;

Hirai, Toshinori ;

Makino, Keishi ;

Kitajima, Mika ;

Murakami, Ryuji ;

Fukuoka, Hirofumi ;

Sasao, Akira ;

Kuratsu, Jun-ichi ;

Yamashita, Yasuyuki .

COMPUTERIZED MEDICAL IMAGING AND GRAPHICS, 2008, 32 (07) :539-543

[2] AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients [J].

Batchelor, Tracy T. ;

Sorensen, A. Gregory ;

di Tomaso, Emmanuelle ;

Zhang, Wei-Ting ;

Duda, Dan G. ;

Cohen, Kenneth S. ;

Kozak, Kevin R. ;

Cahill, Daniel P. ;

Chen, Poe-Jou ;

Zhu, Mingwang ;

Ancukiewicz, Marek ;

Mrugala, Maciej M. ;

Plotkin, Scott ;

Drappatz, Jan ;

Louis, David N. ;

Ivy, Percy ;

Scadden, David T. ;

Benner, Thomas ;

Loeffler, Jay S. ;

Wen, Patrick Y. ;

Jain, Rakesh K. .

CANCER CELL, 2007, 11 (01) :83-95

[3] A phase II, randomized, non-comparative clinical trial of the effect of bevacizumab (BV) alone or in combination with irinotecan (CPT) on 6-month progression free survival (PFS6) in recurrent, treatment-refractory glioblastoma (GBM) [J].

Cloughesy, T. F. ;

Prados, M. D. ;

Wen, P. Y. ;

Mikkelsen, T. ;

Abrey, L. E. ;

Schiff, D. ;

Yung, W. K. ;

Maoxia, Z. ;

Dimery, I. ;

Friedman, H. S. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)

[4]

GERSTNER E, NEUROONCOLO IN PRESS

[5] Functional diffusion map as an early imaging biomarker for high-grade glioma: Correlation with conventional radiologic response and overall survival [J].

Hamstra, Daniel A. ;

Galban, Craig J. ;

Meyer, Charles R. ;

Johnson, Timothy D. ;

Sundgren, Pia C. ;

Tsien, Christina ;

Lawrence, Theodore S. ;

Junck, Larry ;

Ross, David J. ;

Rehemtulla, Alnawaz ;

Ross, Brian D. ;

Chenevert, Thomas L. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (20) :3387-3394

[6] Edema Control by Cediranib, a Vascular Endothelial Growth Factor Receptor-Targeted Kinase Inhibitor, Prolongs Survival Despite Persistent Brain Tumor Growth in Mice [J].

Kamoun, Walid S. ;

Ley, Carsten D. ;

Farrar, Christian T. ;

Duyverman, Annique M. ;

Lahdenranta, Johanna ;

Lacorre, Delphine A. ;

Batchelor, Tracy T. ;

di Tomaso, Emmanuelle ;

Duda, Dan G. ;

Munn, Lance L. ;

Fukumura, Dai ;

Sorensen, A. Gregory ;

Jain, Rakesh K. .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15) :2542-2552

[7]

Kunkel P, 2001, CANCER RES, V61, P6624

[8] Dynamic Imaging of emerging resistance during cancer therapy [J].

Lee, Kuei C. ;

Hall, Daniel E. ;

Hoff, Benjamin A. ;

Moffat, Bradford A. ;

Sharma, Surabhi ;

Chenevert, Thomas L. ;

Meyer, Charles R. ;

Leopold, Wilbur R. ;

Johnson, Timothy D. ;

Mazurchuk, Richard V. ;

Rehemtulla, Alnawaz ;

Ross, Brian D. .

CANCER RESEARCH, 2006, 66 (09) :4687-4692

[9] Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption [J].

Rubenstein, JL ;

Kim, J ;

Ozawa, T ;

Zhang, M ;

Westphal, M ;

Deen, DF ;

Shuman, MA .

NEOPLASIA, 2000, 2 (04) :306-314

[10] Diffusion-weighted MR imaging in monitoring the effect of a vascular targeting agent on rhabdomyosarcoma in rats [J].

Thoeny, HC ;

De Keyzer, F ;

Chen, F ;

Ni, YC ;

Landuyt, W ;

Verbeken, EK ;

Bosmans, H ;

Marchal, G ;

Hermans, R .

RADIOLOGY, 2005, 234 (03) :756-764

← 1 2 →